33 Recruiting Ovarian Cancer Phase 1 Clinical Trials
Active phase 1 studies for ovarian cancer enrolling across the USA. Verify eligibility and contact site coordinators.
All Ovarian Cancer studiesPhase 1 Studies for Ovarian Cancer
NeoVax With Nivolumab in Patients With Ovarian Cancer
📍 Dana Farber Cancer Institute — Boston, Massachusetts
View Study & Checklist ➔Depression Treatment and Screening in Ovarian Cancer Patients
📍 University of Texas MD Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔PARP-inhibition and CTLA-4 Blockade in BRCA-deficient Ovarian Cancer
📍 Moffitt Cancer Center — Tampa, Florida
View Study & Checklist ➔Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies
📍 Research Site — Boston, Massachusetts
View Study & Checklist ➔A Study Evaluating the Immunotherapy Treatment for Ovarian Cancer and Other Advanced Malignancies.
📍 University of Chicago Medicine Comprehensive Cancer Center — Chicago, Illinois
View Study & Checklist ➔Phase 1b of Lurbinectedin in Combination With Weekly Paclitaxel and Bevacizumab in Platinum-resistant Ovarian Cancer
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
📍 City of Hope — Duarte, California
View Study & Checklist ➔Prehabilitation for EOC, Fallopian Tube, Primary Peritoneal Carcinoma and Pancreatic Cancer w/ NACT
📍 Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center — Cleveland, Ohio
View Study & Checklist ➔Sacituzumab Govitecan in Combination With Cisplatin in Platinum Sensitive Recurrent Ovarian and Endometrial Cancer
📍 Icahn School of Medicine at Mount Sinai Division of Hematology and Medical Oncology — New York, New York
View Study & Checklist ➔Study of TUB-040 Given With Standard Ovarian Cancer Drugs in Patients With Fast-growing Ovarian Cancer
📍 Start Cal — Los Angeles, California
View Study & Checklist ➔Using Aspirin to Improve Immunological Features of Ovarian Tumors
📍 Moffitt Cancer Center — Tampa, Florida
View Study & Checklist ➔DT2216 + Paclitaxel in Platinum-Resistant Ovarian Cancer
📍 Beth Israel Deaconess Medical Center (BIDMC) — Boston, Massachusetts
View Study & Checklist ➔Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
📍 Research Site — Duarte, California
View Study & Checklist ➔Study of NMS-03305293 in Adult Patients With Relapsed Ovarian Cancer
📍 OSF Saint Francis Medical Center — Peoria, Illinois
View Study & Checklist ➔Effect of NAC on Preventing Chemo-Related Cognitive Impairments in Ovarian Ca Pts Treated W/ PBT
📍 Chao Family Comprehensive Cancer Center, University of California, Irvine — Orange, California
View Study & Checklist ➔A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab
📍 City of Hope Comprehensive Cancer Center — Duarte, California
View Study & Checklist ➔A Clinical Trial to Evaluate the Safety and Efficacy of COM701 in Relapsed Platinum Sensitive Ovarian Cancer
📍 Georgia Cancer Center at Augusta University — Augusta, Georgia
View Study & Checklist ➔Microdevice In Ovarian, Fallopian Tube, And Peritoneal Cancer
📍 Brigham and Women's Hospital — Boston, Massachusetts
View Study & Checklist ➔A First-in-human, Phase I, Open-label, Multicenter Study of NM1F(Anti-PVRIG) in Patients With Advanced Solid Tumors
📍 NEXT Oncology, Dallas — Dallas, Texas
View Study & Checklist ➔A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Bevacizumab in Adult Participants With Ovarian Cancer
📍 Sarah Cannon Research Institute at HealthONE /ID# 278785 — Denver, Colorado
View Study & Checklist ➔A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors
📍 Sarah Cannon Research Institute at HealthONE — Denver, Colorado
View Study & Checklist ➔Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
📍 University of Southern California — Los Angeles, California
View Study & Checklist ➔Trial of THEO-260 (Administered Via Intraperitoneal Route) in Ovarian Cancer Patients
📍 MD Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC
📍 The University of Alabama — Birmingham, Alabama
View Study & Checklist ➔SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma
📍 Moffitt Cancer Center — Tampa, Florida
View Study & Checklist ➔Clinical Trial of Autologous B7-H3 CAR T Cells in Reoccurent Platinum-resistant Ovarian Tumors
📍 Stanford University — Palo Alto, California
View Study & Checklist ➔Phase 1, Safety and Tolerability Study of XmAb541 and XmAb808 in Advanced Solid Tumors
📍 Xencor Investigative Site — Lake Success, New York
View Study & Checklist ➔A Phase 1 Study of LNCB74 in Advanced Solid Tumors
📍 Hoag Family Cancer Institute — Newport Beach, California
View Study & Checklist ➔A Trial to Evaluate Safety, Tolerability, and Preliminary Efficacy of Misetionamide (GP-2250) as Monotherapy or in Combination With Gemcitabine
📍 Rush University Medical Center — Chicago, Illinois
View Study & Checklist ➔Phase II IMNN-001 (Also Known as GEN-1) on SLL With BEV and NACT, Newly Diagnosed Advanced Ovarian, Fallopian Tube or Primary Peritoneal Cancer
📍 Johns Hopkins Medicine SKCCC — Baltimore, Maryland
View Study & Checklist ➔Safety and Immunogenicity of Innocell Autologous Cellular Immunotherapy for Recurrent Epithelial Ovarian Cancer
📍 City of Hope — Duarte, California
View Study & Checklist ➔Phase 1 Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of ARR-002 in Advanced or Metastatic Ovarian or Endometrial Cancer.
📍 NEXT Oncology — Irving, Texas
View Study & Checklist ➔Infusion of Autologous T Cells Engineered to Target FSH Receptor in Recurrent Ovarian Cancer
📍 Moffitt Cancer Center — Tampa, Florida
View Study & Checklist ➔